Medefile International, Inc. - FORM 8-K - September 27, 2012
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________________________________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
___________________________________________________________________
Date of Report (Date of earliest event reported): September 21, 2012
MedeFile International, Inc.
(Exact Name of Registrant as Specified in Charter)
|
Nevada
|
033-25126 D
|
85-0368333
|
|
(State or other jurisdiction
of incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
|
301 Yamato Road
Suite 1200
Boca Raton, FL
|
33431
|
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant’s telephone number, including area code: (561) 912-3393
|
(Former name or former address, if changed since last report)
|
|
Copies to:
Richard A. Friedman, Esq.
Jeff Cahlon, Esq.
Sichenzia Ross Friedman Ference LLP
61 Broadway, 32 nd Floor
New York, New York 10006
Telephone: (212) 930-9700
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
1
On September 21, 2012, shareholders of MedeFile International, Inc. (the “Company”), owning an aggregate of 37,108,962,098 shares of common stock of the Company, representing approximately 69.3% of the Company’s 53,540,494,067 issued and outstanding shares of common stock, approved by written consent an amendment to the Company’s articles of incorporation, pursuant to which, upon filing with the Secretary of State of Nevada, (i) the Company will effect a 5,000-to-1 reverse split of its common stock and (ii) the number of authorized shares of the Company’s common stock will decrease from 75,000,000,000 to 100,000,000.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
MEDEFILE INTERNATIONAL, INC.
|
|||
|
Date: September 27, 2012
|
By:
|
/s/ Kevin Hauser
|
|
|
Name: Kevin Hauser
|
|||
|
Title: Chief Executive Officer
|
|||
2
User Contributions:
Comment about this document or add new information about this topic:
This web site and associated pages are not associated with, endorsed by, or sponsored by Medefile International, Inc. and has no official or unofficial affiliation with Medefile International, Inc.
Based on public records. Inadvertent errors are possible.
Faqs.org does not guarantee the accuracy or timeliness of any information on this site. Use at your own risk.
This website is not associated with the SEC
Some parts © 2013 Advameg, Inc.
